Skip to content

Antares Coronary Stent System to Facilitate Side Branch Interventions

Treatment sucess with the Antares Stent System for Coronary Artery Stenting at or near a Major Sidebranch

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000487213
Acronym
TOP II
Enrollment
2
Registered
2009-06-18
Start date
2009-07-15
Completion date
2009-08-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Study to evalute the use of the Antares Stent System in patients with coronary disease at a location where two vessels are meeting.

Interventions

Coronary Stenting involves placing a metal mesh in a blood vessel in the heart to open a blockage. The stent is inserted through a blood vessel in the arm or leg and is put in place by inflating a balloon inside the stent. The stent cannot be removed from the blood vessel once it is in place.

Sponsors

TriReme Medical, Inc.
Lead SponsorCommercial sector/Industry

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

symptomatic or documented myocardial ischemia, study lesion is a single bifurcation lesion that has not been previously treated, By angiograpic review the study lesion has a diameter and length appropriate for Antares Stent,

Exclusion criteria

Acute myocardial infarction, Shock, Stroke, Coagulopathy, Left main coronary lesion, Total occlusion, Diffuse disease, thrombus or severe calcification, Previous Coronary Artery Bypass Graft (CABG) surgery,

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026